Premium Nahrungsergänzungsmittel | artgerecht

Cyclooxygenase (COX) -- Enzyme, Function & Importance

Cyclooxygenase (COX) is an enzyme that plays a central role in the production of prostaglandins and inflammatory mediators in the human body.

Regular tips about health Regular tips about health

Things worth knowing about "Cyclooxygenase"

Cyclooxygenase (COX) is an enzyme that plays a central role in the production of prostaglandins and inflammatory mediators in the human body.

What is Cyclooxygenase?

Cyclooxygenase (abbreviated as COX) is an enzyme that plays a key role in the formation of inflammation, pain, and fever in the human body. Enzymes are biological catalysts that accelerate chemical reactions within cells. Cyclooxygenase catalyzes the conversion of arachidonic acid -- an unsaturated fatty acid -- into prostaglandins, thromboxanes, and prostacyclins. These signaling molecules, collectively known as eicosanoids, regulate a wide range of bodily functions, including inflammatory responses, blood clotting, and the protection of the stomach lining.

Isoforms of Cyclooxygenase

Two major isoforms of cyclooxygenase have been identified, each differing in function and distribution throughout the body:

COX-1: This isoform is constitutively expressed, meaning it is continuously produced in nearly all cell types. It is responsible for generating prostaglandins that protect the gastric mucosa, regulate kidney function, and promote platelet aggregation.
COX-2: This isoform is primarily induced in response to inflammatory stimuli, tissue damage, or certain hormones. It is mainly involved in producing prostaglandins that mediate inflammation, pain, and fever. However, COX-2 is also expressed under normal physiological conditions in certain tissues such as the brain and kidneys.
COX-3: A splice variant of COX-1 that may be involved in the mechanism of action of paracetamol (acetaminophen), though its clinical significance is not yet fully established.

Mechanism of Action

Cyclooxygenase catalyzes two sequential enzymatic reactions:

Cyclooxygenase reaction: Arachidonic acid is converted into prostaglandin G2 (PGG2).
Peroxidase reaction: PGG2 is subsequently reduced to prostaglandin H2 (PGH2).

PGH2 then serves as the precursor for the synthesis of various prostaglandins, thromboxanes, and prostacyclins, which exert diverse biological effects -- ranging from vasodilation to the sensitization of pain receptors.

Clinical Importance and Pharmacological Inhibition

Cyclooxygenase is one of the most important drug targets in medicine and is the primary target of nonsteroidal anti-inflammatory drugs (NSAIDs), one of the most widely used medication classes worldwide. By inhibiting COX enzymes, these drugs suppress prostaglandin production and thereby exert anti-inflammatory, analgesic (pain-relieving), and antipyretic (fever-reducing) effects.

Non-selective COX inhibitors (e.g., ibuprofen, diclofenac, naproxen, aspirin/acetylsalicylic acid) inhibit both COX-1 and COX-2. Because they also block COX-1-mediated protection of the gastric lining, gastrointestinal side effects such as stomach ulcers may occur.
Selective COX-2 inhibitors (known as coxibs, e.g., celecoxib, etoricoxib) were developed to selectively target COX-2, thereby reducing gastrointestinal side effects. However, coxibs have been associated with an increased risk of cardiovascular events, which must be carefully considered during prescribing.

Relevance in Medical Research

Cyclooxygenase continues to be a major focus of biomedical research. Studies have explored the role of COX-2 in cancer development, as elevated COX-2 activity has been observed in various tumor tissues. COX enzymes are also being investigated in the context of Alzheimer disease and cardiovascular disease, making them relevant targets for future therapeutic development.

References

Vane, J. R. et al. (1998): Cyclooxygenases 1 and 2. In: Annual Review of Pharmacology and Toxicology, 38, pp. 97--120.
Bhatt, D. L. et al. (2002): Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. In: JAMA, 289(7), pp. 954--960.
FitzGerald, G. A. & Patrono, C. (2001): The Coxibs, selective inhibitors of cyclooxygenase-2. In: New England Journal of Medicine, 345(6), pp. 433--442.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.